The limitations of QALY: a literature review

The limitations of QALY: a literature review

<p>Introduction: The Quality Adjusted Life Year (QALY) is a recognised metric used to evaluate new and innovative healthcare treatments and optimise resource allocation via rational and explicit methodologies. This review examines present limitations of the QALY metric and foreseeable challeng...

Full description

Bibliographic Details
Main Authors:	Pettitt, D, Raza, S, Naughton, B, Roscoe, A, Ramakrishnan, A, Ali, A, Davies, B, Dopson, S, Hollander, G, Smith, J, Brindley, D
Format:	Journal article
Language:	English
Published:	OMICS International 2016

Similar Items

Bursting bubbles? QALYs and discrimination
by: Davies, B
Published: (2018)

A QALY is [still] a QALY is [still] a QALY?
by: Hamideh Mahdiani, et al.
Published: (2024-03-01)

QALYs: The Basics
by: M. C. Weinstein, et al.
Published: (2018-05-01)

Retaining, and Enhancing, the QALY
by: Joseph Lipscomb, et al.
Published: (2018-05-01)

Toward a Consensus on the QALY
by: Michael Drummond, et al.
Published: (2018-05-01)

QALYs: The Math Doesn’t Work
by: Tia G. Sawhney, et al.
Published: (2023-07-01)

EU Falsified Medicines Directive mandatory requirements for secondary care: A concise review
by: Naughton, B, et al.
Published: (2016)

The QALY at 50: one story many voices
by: Spencer, A, et al.
Published: (2021)

Insufficiency in the reporting of CAR-T manufacturing protocols - a systematic review and mixed-methods analysis
by: Pettitt, D, et al.
Published: (2018)

QALY: Quality Adjusted Life Year
by: Selale Sahin, et al.
Published: (2012-09-01)

Cell therapy commercialization: An assessment of translational barriers
by: Pettitt, D, et al.
Published: (2016)

CAR-T Cells: A systematic review and mixed methods analysis of the clinical trial landscape
by: Pettitt, D, et al.
Published: (2017)

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol
by: Pettitt, D, et al.
Published: (2017)

Balancing principles, QALYs, and the straw men of resource allocation.
by: McMillan, J, et al.
Published: (2010)

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)
by: Halioua-Haubold, C, et al.
Published: (2018)

The Use of QALYs in Clinical and Patient Decision-Making: Issues and Prospects
by: Paul Kind, et al.
Published: (2018-05-01)

Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study.
by: Naughton, B, et al.
Published: (2016)

Medicine authentication technology as a counterfeit medicine-detection tool: a Delphi method study to establish expert opinion on manual medicine authentication technology in secondary care
by: Naughton, B, et al.
Published: (2017)

Methodological challenges surrounding QALY estimation for paediatric economic evaluation
by: Petrou, S
Published: (2022)

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
by: N. Z. Musina, et al.
Published: (2017-05-01)

Using QALYs as an outcome for assessing global prediction accuracy in diabetes simulation models
by: Dakin, H, et al.
Published: (2024)

Appendix A: Legal framework on the scientific use of animals in research
by: Pettitt, D, et al.
Published: (2017)

After The QALY: Training for a New Start Paradigm in Health Technology Assessment
by: Paul C Langley, et al.
Published: (2023-03-01)

The societal monetary value of a QALY associated with EQ-5D-3L health gains
by: Vallejo-Torres, L, et al.
Published: (2019)

Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety
by: Naughton, B, et al.
Published: (2016)

Valuing infertility treatment: Why QALYs are inadequate, and an alternative approach to cost-effectiveness thresholds
by: Elena Keller, et al.
Published: (2022-12-01)

Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality
by: Arshad, Z, et al.
Published: (2016)

Cell assisted lipotransfer in breast augmentation and reconstruction: A systematic review of safety, efficacy, use of patient reported outcomes and study quality
by: Smith, J, et al.
Published: (2016)

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol
by: Pettitt, David, et al.
Published: (2017)

The Impacts of COVID-19 Restrictions on Quality Adjusted Life Years (QALY): Heterogeneous effects and post-pandemic recovery.
by: Raimundo Atal, et al.
Published: (2024-01-01)

Regulatory barriers to the advancement of precision medicine
by: Pettitt, D, et al.
Published: (2016)

Modelo de gestión de conocimiento para el programa nacional de alimentación escolar Qali Warma
by: Blanca F. Simón-Díaz, et al.
Published: (2020-01-01)

Cisplatin reduces costs and provides more quality adjusted life years (QALYs) than cetuximab in chemoradiotherapy for patients with HPV-positive oropharyngeal cancer (HPV+OPC)
by: Jones, D, et al.
Published: (2019)

Emerging platform bioprocesses for viral vectors and gene therapies
by: Pettitt, D, et al.
Published: (2016)

Estimating risk factor time paths among people with Type 2 Diabetes and QALY gains from risk factor management
by: Gao, N, et al.
Published: (2024)

Is the Use of DALYs and QALYs Ethically Permissible in Triage Decisions? COVID-19 and Equity Considerations from a Queer-Crip Perspective
by: Lautaro Leani, et al.
Published: (2023-11-01)

Automation of CAR-T cell adoptive immunotherapy bioprocessing: Technology opportunities to debottleneck manufacturing
by: Bure, K, et al.
Published: (2016)

Scalable purification of viral vectors for gene therapy: An appraisal of downstream processing approaches
by: Fuerstenau-Sharp, M, et al.
Published: (2017)

Adipose-derived stem cells in aesthetic surgery: a mixed methods evaluation of the current clinical trial, intellectual property, and regulatory landscape
by: Arshad, Z, et al.
Published: (2017)

Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study
by: Laura Ulbrich, et al.
Published: (2021-12-01)